Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults (clinicaltrials.gov) - Oct 17, 2022 - P3 | N=1822 | Recruiting | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | Trial completion date: Apr 2023 ➔ Oct 2023 | Trial primary completion date: Oct 2022 ➔ Mar 2023
Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|